Compared with the PBS treatment group, the percentages of CD4+CD25+Foxp3+ Treg cells obtained from the splenic, thymic and peripheral blood cells in the severe SLE mice treated with LZ–SMS increased significantly (all P < 0.05). The gene discussed is FOXP3; the disease is systemic lupus erythematosus.